Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 biotech developing UCP1-activating thermogenesis drugs for obesity competing with GLP-1 agonists; seed-stage with proprietary HTS platform targeting brown fat calorie burning as next-generation anti-obesity mechanism.
Equator Therapeutics is a San Francisco-based early-stage biopharmaceutical company — backed by Y Combinator (W20) with seed funding from BioGenerator Ventures, Thoobik Holdings, Healthspan Capital, Endurance28, and Evolution VC Partners — developing first-in-class small molecule drugs that activate uncoupling protein 1 (UCP1) in brown and beige adipose tissue to increase metabolic rate and burn excess calories as heat, targeting obesity, metabolic syndrome, and related cardiometabolic diseases with a mechanism of action distinct from GLP-1 agonists (Ozempic, Wegovy) and traditional anti-obesity medications. Founded in 2019, Equator has developed a proprietary high-throughput drug discovery platform to identify selective UCP1 activators — compounds that safely activate the body's natural thermogenesis mechanism without the side effects (nausea, cardiovascular risk) that have limited previous metabolic drug programs.
Largest US chicken QSR with $22B+ system sales; highest revenue per restaurant in fast food through exceptional service culture and tight franchise operator standards.
Chick-fil-A is the largest US quick-service chicken restaurant chain, generating over $22 billion in annual system-wide sales from approximately 3,000 locations — more revenue per restaurant than any other US fast food chain, including McDonald's. Founded in 1946 by S. Truett Cathy in Hapeville, Georgia, Chick-fil-A pioneered the chicken sandwich and built a brand synonymous with exceptional customer service, clean restaurants, and a distinctive cultural identity. The company is privately held by the Cathy family.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.